MRI for breast cancer screening, diagnosis, and treatment

The Lancet

Volumn 378, Issue 9805, 2011, Pages 1804-1811

  Morrow, Monica ^a   Waters, Janet ^a   Morris, Elizabeth ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; CYTOTOXIC AGENT; TAMOXIFEN;

ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER PATIENT; CANCER RECURRENCE; CANCER RISK; CANCER SCREENING; CANCER SIZE; COMPARATIVE EFFECTIVENESS; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; ECHOGRAPHY; FAMILY HISTORY; GENE MUTATION; HEALTH CARE COST; HIGH RISK POPULATION; HUMAN; INTERMETHOD COMPARISON; INTRADUCTAL CARCINOMA; IPSILATERAL BREAST TUMOUR RECURRENCE; LYMPH NODE; MAMMOGRAPHY; META ANALYSIS (TOPIC); NUCLEAR MAGNETIC RESONANCE IMAGING; OCCULT CANCER; PARTIAL MASTECTOMY; PREDICTION; PRIORITY JOURNAL; REOPERATION; SENSITIVITY AND SPECIFICITY; SYSTEMIC THERAPY;

EID: 81555213207     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(11)61350-0     Document Type: Review

References (62)

1. PC Gotzsche, M Nielsen Screening for breast cancer with mammography Cochrane Database Syst Rev 1 2011 CD001877.
2. M Morrow, R Jagsi, AK Alderman et al. Surgeon recommendations and receipt of mastectomy for treatment of breast cancer JAMA 302 2009 1551 1556
3. SJ Anderson, I Wapnir, JJ Dignam et al. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer J Clin Oncol 27 2009 2466 2473
4. K Kerlikowske Efficacy of screening mammography among women aged 40 to 49 years and 50 to 69 years: comparison of relative and absolute benefit J Natl Cancer Inst Monogr 22 1997 79 86
5. SJ Otto, J Fracheboud, CW Looman et al. Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review Lancet 361 2003 1411 1417 (Pubitemid 36515040)
6. CT Brekelmans, C Seynaeve, CC Bartels et al. Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk J Clin Oncol 19 2001 924 930 (Pubitemid 32176266)
7. CK Kuhl, S Schrading, CC Leutner et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer J Clin Oncol 23 2005 8469 8476
8. SR Lakhani, J Jacquemier, JP Sloane et al. Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations J Natl Cancer Inst 90 1998 1138 1145 (Pubitemid 28380718)
9. ED Pisano, C Gatsonis, E Hendrick et al. Diagnostic performance of digital versus film mammography for breast-cancer screening N Engl J Med 353 2005 1773 1783 (Pubitemid 41549889)
10. F Sardanelli, GM Giuseppetti, P Panizza et al. Sensitivity of MRI versus mammography for detecting foci of multifocal, multicentric breast cancer in fatty and dense breasts using the whole-breast pathologic examination as a gold standard Am J Roentgenol 183 2004 1149 1157 (Pubitemid 44185114)
11. E Warner, H Messersmith, P Causer, A Eisen, R Shumak, D Plewes Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer Ann Intern Med 148 2008 671 679 (Pubitemid 351669112)
12. E Warner, DB Plewes, KA Hill et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination JAMA 292 2004 1317 1325 (Pubitemid 39223222)
13. M Kriege, CT Brekelmans, C Boetes et al. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition N Engl J Med 351 2004 427 437
14. MO Leach, CR Boggis, AK Dixon et al. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS) Lancet 365 2005 1769 1778 (Pubitemid 40744657)
15. AI Hagen, KA Kvistad, L Maehle et al. Sensitivity of MRI versus conventional screening in the diagnosis of BRCA-associated breast cancer in a national prospective series Breast 16 2007 367 374 (Pubitemid 47157808)
16. CK Kuhl, S Schrading, HB Bieling et al. MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study Lancet 370 2007 485 492 (Pubitemid 47214635)
17. I Griebsch, J Brown, C Boggis et al. Cost-effectiveness of screening with contrast enhanced magnetic resonance imaging vs X-ray mammography of women at a high familial risk of breast cancer Br J Cancer 95 2006 801 810 (Pubitemid 44498093)
18. TO Henderson, A Amsterdam, S Bhatia et al. Systematic review: surveillance for breast cancer in women treated with chest radiation for childhood, adolescent, or young adult cancer Ann Intern Med 152 2010 444 455
19. ER Port, A Park, PI Borgen, E Morris, LL Montgomery Results of MRI screening for breast cancer in high-risk patients with LCIS and atypical hyperplasia Ann Surg Oncol 14 2007 1051 1057
20. D Saslow, C Boetes, W Burke et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography CA Cancer J Clin 57 2007 75 89 (Pubitemid 46535708)
21. N Houssami, S Ciatto, P Macaskill et al. Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer J Clin Oncol 26 2008 3248 3258
22. NH Peters, S van Esser, MA van den Bosch et al. Preoperative MRI and surgical management in patients with nonpalpable breast cancer: the MONET - randomised controlled trial Eur J Cancer 47 2011 879 886
23. L Turnbull, S Brown, I Harvey et al. Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial Lancet 375 2010 563 571
24. RJ Bleicher, RM Ciocca, BL Egleston et al. Association of routine pretreatment magnetic resonance imaging with time to surgery, mastectomy rate, and margin status J Am Coll Surg 209 2009 180 187
25. N Hwang, DE Schiller, P Crystal, E Maki, DR McCready Magnetic resonance imaging in the planning of initial lumpectomy for invasive breast carcinoma: its effect on ipsilateral breast tumor recurrence after breast-conservation therapy Ann Surg Oncol 16 2009 3000 3009
26. KE Pengel, CE Loo, HJ Teertstra et al. The impact of preoperative MRI on breast-conserving surgery of invasive cancer: a comparative cohort study Breast Cancer Res Treat 116 2009 161 169
27. LJ McGhan, N Wasif, RJ Gray et al. Use of preoperative magnetic resonance imaging for invasive lobular cancer: good, better, but maybe not the best? Ann Surg Oncol 17 suppl 3 2010 255 262
28. RM Mann, CE Loo, T Wobbes et al. The impact of preoperative breast MRI on the re-excision rate in invasive lobular carcinoma of the breast Breast Cancer Res Treat 119 2010 415 422
29. LR Allen, CE Lago-Toro, JH Hughes et al. Is there a role for MRI in the preoperative assessment of patients with DCIS? Ann Surg Oncol 17 2010 2395 2400
30. ME Brennan, N Houssami, S Lord et al. Magnetic resonance imaging screening of the contralateral breast in women with newly diagnosed breast cancer: systematic review and meta-analysis of incremental cancer detection and impact on surgical management J Clin Oncol 27 2009 5640 5649
31. CD Lehman, JD Blume, D Thickman et al. Added cancer yield of MRI in screening the contralateral breast of women recently diagnosed with breast cancer: results from the International Breast Magnetic Resonance Consortium (IBMC) trial J Surg Oncol 92 2005 9 15 (Pubitemid 41416422)
32. CD Lehman, C Gatsonis, CK Kuhl et al. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer N Engl J Med 356 2007 1295 1303 (Pubitemid 46513295)
33. F Pediconi, C Catalano, A Roselli et al. Contrast-enhanced MR mammography for evaluation of the contralateral breast in patients with diagnosed unilateral breast cancer or high-risk lesions Radiology 243 2007 670 680 (Pubitemid 46799419)
34. HB Nichols, AB de Gonzalez, JV Lacey Jr, PS Rosenberg, WF Anderson Declining incidence of contralateral breast cancer in the United States from 1975 to 2006 J Clin Oncol 29 2011 1564 1569
35. Early Breast Cancer Trialists' Collaborative Group Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials Lancet 365 2005 1687 1717
36. LJ Solin, SG Orel, WT Hwang, EE Harris, MD Schnall Relationship of breast magnetic resonance imaging to outcome after breast-conservation treatment with radiation for women with early-stage invasive breast carcinoma or ductal carcinoma in situ J Clin Oncol 26 2008 386 391 (Pubitemid 351171689)
37. U Fischer, O Zachariae, F Baum, D von Heyden, M Funke, T Liersch The influence of preoperative MRI of the breasts on recurrence rate in patients with breast cancer Eur Radiol 14 2004 1725 1731 (Pubitemid 39386618)
38. B Fisher, J Dignam, EP Mamounas et al. Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: eight-year results from National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of findings from NSABP B-19 comparing methotrexate and fluorouracil with conventional cyclophosphamide, methotrexate, and fluorouracil J Clin Oncol 14 1996 1982 1992
39. JS Mieog, JA van der Hage, CJ van de Velde Neoadjuvant chemotherapy for operable breast cancer Br J Surg 94 2007 1189 1200 (Pubitemid 47584766)
40. Y Yuan, XS Chen, SY Liu, KW Shen Accuracy of MRI in prediction of pathologic complete remission in breast cancer after preoperative therapy: a meta-analysis Am J Roentgenol 195 2010 260 268
41. Blue Cross Blue Shield Association (BCBS) Breast MRI for management of patients with locally advanced breast cancer who are being referred for neoadjuvant chemotherapy 2011 John Wiley and Sons: Health Technology Assessment Database Issue 2
42. E Yeh, P Slanetz, DB Kopans et al. Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer Am J Roentgenol 184 2005 868 877 (Pubitemid 43899515)
43. C Balu-Maestro, C Chapellier, A Bleuse, I Chanalet, C Chauvel, R Largillier Imaging in evaluation of response to neoadjuvant breast cancer treatment benefits of MRI Breast Cancer Res Treat 72 2002 145 152 (Pubitemid 34407209)
44. M Bhattacharyya, D Ryan, R Carpenter, S Vinnicombe, CJ Gallagher Using MRI to plan breast-conserving surgery following neoadjuvant chemotherapy for early breast cancer Br J Cancer 98 2008 289 293 (Pubitemid 351161258)
45. MA Bollet, F Thibault, K Bouillon et al. Role of dynamic magnetic resonance imaging in the evaluation of tumor response to preoperative concurrent radiochemotherapy for large breast cancers: a prospective phase II study Int J Radiat Oncol Biol Phys 69 2007 13 18 (Pubitemid 47247496)
46. D Segara, IE Krop, JE Garber et al. Does MRI predict pathologic tumor response in women with breast cancer undergoing preoperative chemotherapy? J Surg Oncol 96 2007 474 480 (Pubitemid 350044390)
47. RM Warren, LG Bobrow, HM Earl et al. Can breast MRI help in the management of women with breast cancer treated by neoadjuvant chemotherapy? Br J Cancer 90 2004 1349 1360 (Pubitemid 38586259)
48. T Julius, SE Kemp, PJ Kneeshaw, A Chaturvedi, PJ Drew, LW Turnbull MRI and conservative treatment of locally advanced breast cancer Eur J Surg Oncol 31 2005 1129 1134 (Pubitemid 41819197)
49. JH Chen, B Feig, G Agrawal et al. MRI evaluation of pathologically complete response and residual tumors in breast cancer after neoadjuvant chemotherapy Cancer 112 2008 17 26
50. M Douek, J Tobias How reliable is MRI for predicting extent of residual breast cancer with different primary medical therapies? Nat Clin Pract Oncol 2 2005 128 129 (Pubitemid 40823160)
51. HG Moon, W Han, JW Lee et al. Age and HER2 expression status affect MRI accuracy in predicting residual tumor extent after neo-adjuvant systemic treatment Ann Oncol 20 2009 636 641
52. S Bloom, M Morrow A clinical oncologic perspective on breast magnetic resonance imaging Magn Reson Imaging Clin N Am 18 2010 277 294
53. J de Bresser, B de Vos, F van der Ent, K Hulsewe Breast MRI in clinically and mammographically occult breast cancer presenting with an axillary metastasis: a systematic review Eur J Surg Oncol 36 2010 114 119
54. WD Foulkes, IM Stefansson, PO Chappuis et al. Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer J Natl Cancer Inst 95 2003 1482 1485 (Pubitemid 37279334)
55. EP Mamounas, G Tang, B Fisher et al. Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20 J Clin Oncol 28 2010 1677 1683
56. EK Millar, PH Graham, SA O'Toole et al. Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panel J Clin Oncol 27 2009 4701 4708
57. M Kyndi, FB Sorensen, H Knudsen, M Overgaard, HM Nielsen, J Overgaard Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group J Clin Oncol 26 2008 1419 1426
58. M Clarke, R Collins, S Darby et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials Lancet 366 2005 2087 2106 (Pubitemid 41797643)
59. HD Bear, S Anderson, A Brown et al. The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27 J Clin Oncol 21 2003 4165 4174 (Pubitemid 46606185)
60. L Bartella, SB Thakur, EA Morris et al. Enhancing nonmass lesions in the breast: evaluation with proton (1H) MR spectroscopy Radiology 245 2007 80 87 (Pubitemid 47417790)
61. AE Giuliano, KK Hunt, KV Ballman et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial JAMA 305 2011 569 575
62. AE Giuliano, L McCall, P Beitsch et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial Ann Surg 252 2010 426 432